Vaxinano is changing scale. The Lille-based biotech, which has validated its Stellar-NP platform...
News & Publications
New Study Confirms Cross-Strain T-Cell Immunity Induced by VXN-Toxo
A newly published study in Pharmaceutics provides fresh insight into the immune mechanisms behind...
Vaxinano and ECO Animal Health Sign Exclusive Licensing Agreement for Toxoplasmosis Vaccine
Vaxinano is pleased to announce the signing of an exclusive licensing agreement with ECO Animal...
Field Evidence Highlights the Potential of VXN-Toxo Against Toxoplasmosis in Captive Wildlife
Proud to share a new testimony highlighting the impact and importance of VXN-Toxo. VXN-Toxo is an...
Vaxinano Shares Latest Vaccine Immunology Advances at Colloque I3M
Vaxinano was proud to participate in the latest edition of the Colloque I3M, where the team shared...
Pioneering Inactivated In Ovo Vaccination for Avian Colibacillosis
We’re proud to share our latest publication in MDPI Animals: “Safety, Immunogenicity, and Vaccine...